SCHEMBL21273058

SCHEMBL21273058

Cc1ccc([C@@H](CC(=O)O)C(F)(F)F)s1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.40
DAO P14920 2/20 0.38
KMT2A Q03164 2/20 0.37
POLB P06746 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
USP7 Q93009 1/20 0.36
GABBR2 O75899 1/20 0.36
GABBR1 Q9UBS5 1/20 0.36
FFAR1 O14842 4/20 0.34
HSD17B2 P37059 1/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33
CTSA P10619 2/20 0.32
TAS1R3 Q7RTX0 1/20 0.32
TAS1R1 Q7RTX1 1/20 0.32
IDO1 P14902 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21273024 1.00 ALOX5 (0.40) ALOX5DAOKMT2APOLBTDP1
SCHEMBL9489532 0.78 ALOX5 (0.49) ALOX5DAOKMT2APOLBTDP1
SCHEMBL164188 0.76 ALOX5 (0.44) ALOX5DAOKMT2APOLBTDP1
SCHEMBL1520622 0.75 ALOX5 (0.46) ALOX5DAOKMT2APOLBTDP1
SCHEMBL10740698 0.75 ALDH1A1 (0.44) ALOX5DAOKMT2APOLBTDP1
SCHEMBL25152496 0.74 ALOX5 (0.35) ALOX5DAOKMT2APOLBTDP1
SCHEMBL25152456 0.74 ALOX5 (0.35) ALOX5DAOKMT2APOLBTDP1
SCHEMBL341475 0.72 GABBR2 (0.67) ALOX5DAOKMT2AGABBR2GABBR1
SCHEMBL10747456 0.71 FFAR1 (0.49) ALOX5DAOKMT2APOLBTDP1
SCHEMBL25471154 0.70 ALOX5 (0.41) ALOX5DAOKMT2APOLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4026832-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 Almac Discovery Limited (GB) 2022-07-13 EP disclosed
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 ALMAC DISCOVERY LIMITED (GB) 2020-09-08 US disclosed
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 GENETECH, INC. 2019-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 USP7, USP5, UBA7 ALOX5 4083/4885DAO 2068/4885KMT2A 1051/4885
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 USP7, USP5, UBA7 ALOX5 4083/4885DAO 2068/4885KMT2A 1051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.